OGT-719
OGT-719 is a potent, orally active nucleoside analogue that targets the asialoglycoprotein receptor (ASGP-R) . OGT-719 inhibits growth of metastatic colorectal tumors in the liver of nude mice. OGT-719 can be used for primary hepatocellular carcinoma and colorectal liver metastases research[1].
Product Specifications
CAS Number
185843-61-2
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Asialoglycoprotein Receptor (ASGPR) ; Nucleoside Antimetabolite/Analog
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C1NC(C(F)=CN1[C@H]2[C@@H]([C@H]([C@H]([C@@H](CO)O2)O)O)O)=O
Molecular Formula
C10H13FN2O7
Molecular Weight
292.22
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Emopamil binding Protein (sterol isomerase) discontinued
Tetrahydrocannabinol (THC) (APC) discontinued, see T2970-05A-APC
